138 related articles for article (PubMed ID: 35114637)
1. Evidence from a BreastScreen cohort does not support a longer inter-screen interval in women who have no conventional risk factors for breast cancer.
Noguchi N; Marinovich ML; Wylie EJ; Lund HG; Houssami N
Breast; 2022 Apr; 62():16-21. PubMed ID: 35114637
[TBL] [Abstract][Full Text] [Related]
2. Screening outcomes by risk factor and age: evidence from BreastScreen WA for discussions of risk-stratified population screening.
Noguchi N; Marinovich ML; Wylie EJ; Lund HG; Houssami N
Med J Aust; 2021 Oct; 215(8):359-365. PubMed ID: 34374095
[TBL] [Abstract][Full Text] [Related]
3. Pilot trial of digital breast tomosynthesis (3D mammography) for population-based screening in BreastScreen Victoria.
Houssami N; Lockie D; Clemson M; Pridmore V; Taylor D; Marr G; Evans J; Macaskill P
Med J Aust; 2019 Oct; 211(8):357-362. PubMed ID: 31448816
[TBL] [Abstract][Full Text] [Related]
4. Two-year follow-up of participants in the BreastScreen Victoria pilot trial of tomosynthesis versus mammography: breast density-stratified screening outcomes.
Houssami N; Lockie D; Giles M; Noguchi N; Marr G; Marinovich ML
Br J Radiol; 2023 Aug; 96(1148):20230081. PubMed ID: 37191331
[TBL] [Abstract][Full Text] [Related]
5. Evidence of the effect of adjunct ultrasound screening in women with mammography-negative dense breasts: interval breast cancers at 1 year follow-up.
Corsetti V; Houssami N; Ghirardi M; Ferrari A; Speziani M; Bellarosa S; Remida G; Gasparotti C; Galligioni E; Ciatto S
Eur J Cancer; 2011 May; 47(7):1021-6. PubMed ID: 21211962
[TBL] [Abstract][Full Text] [Related]
6. BreastScreen-based mammography screening in women with a personal history of breast cancer, Western Australian study.
Houssami N; Tresham JJ; Fritschi L; Wylie LE
Med J Aust; 2011 Oct; 195(8):460-4. PubMed ID: 22004397
[TBL] [Abstract][Full Text] [Related]
7. Effect of implementing digital breast tomosynthesis (DBT) instead of mammography on population screening outcomes including interval cancer rates: Results of the Trento DBT pilot evaluation.
Bernardi D; Gentilini MA; De Nisi M; Pellegrini M; Fantò C; Valentini M; Sabatino V; Luparia A; Houssami N
Breast; 2020 Apr; 50():135-140. PubMed ID: 31607526
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Supplemental Imaging on Interval Cancer Rates in Mammography Screening: Systematic Review.
Zeng A; Brennan ME; Young S; Mathieu E; Houssami N
Clin Breast Cancer; 2022 Apr; 22(3):212-222. PubMed ID: 34756834
[TBL] [Abstract][Full Text] [Related]
9. Artificial intelligence (AI) for breast cancer screening: BreastScreen population-based cohort study of cancer detection.
Marinovich ML; Wylie E; Lotter W; Lund H; Waddell A; Madeley C; Pereira G; Houssami N
EBioMedicine; 2023 Apr; 90():104498. PubMed ID: 36863255
[TBL] [Abstract][Full Text] [Related]
10. Breast Density and Risk of Interval Cancers: The Effect of Annual Versus Biennial Screening Mammography Policies in Canada.
Seely JM; Peddle SE; Yang H; Chiarelli AM; McCallum M; Narasimhan G; Zakaria D; Earle CC; Fung S; Bryant H; Nicholson E; Politis C; Berg WA
Can Assoc Radiol J; 2022 Feb; 73(1):90-100. PubMed ID: 34279132
[TBL] [Abstract][Full Text] [Related]
11. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study.
Nederend J; Duijm LE; Voogd AC; Groenewoud JH; Jansen FH; Louwman MW
Breast Cancer Res; 2012 Jan; 14(1):R10. PubMed ID: 22230363
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of screening mammography in women with a history of lobular carcinoma in situ or atypical hyperplasia of the breast.
Houssami N; Abraham LA; Onega T; Collins LC; Sprague BL; Hill DA; Miglioretti DL
Breast Cancer Res Treat; 2014 Jun; 145(3):765-73. PubMed ID: 24800915
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of prospective studies evaluating breast cancer detection and interval cancer rates for digital breast tomosynthesis versus mammography population screening.
Houssami N; Zackrisson S; Blazek K; Hunter K; Bernardi D; Lång K; Hofvind S
Eur J Cancer; 2021 May; 148():14-23. PubMed ID: 33706172
[TBL] [Abstract][Full Text] [Related]
14. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
[TBL] [Abstract][Full Text] [Related]
15. Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer.
Houssami N; Abraham LA; Miglioretti DL; Sickles EA; Kerlikowske K; Buist DS; Geller BM; Muss HB; Irwig L
JAMA; 2011 Feb; 305(8):790-9. PubMed ID: 21343578
[TBL] [Abstract][Full Text] [Related]
16. Breast screening using 2D-mammography or integrating digital breast tomosynthesis (3D-mammography) for single-reading or double-reading--evidence to guide future screening strategies.
Houssami N; Macaskill P; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Ciatto S
Eur J Cancer; 2014 Jul; 50(10):1799-1807. PubMed ID: 24746887
[TBL] [Abstract][Full Text] [Related]
17. Breast Cancer Screening Using Tomosynthesis or Mammography: A Meta-analysis of Cancer Detection and Recall.
Marinovich ML; Hunter KE; Macaskill P; Houssami N
J Natl Cancer Inst; 2018 Sep; 110(9):942-949. PubMed ID: 30107542
[TBL] [Abstract][Full Text] [Related]
18. A prospective comparative trial of adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts (ASTOUND-2).
Tagliafico AS; Mariscotti G; Valdora F; Durando M; Nori J; La Forgia D; Rosenberg I; Caumo F; Gandolfo N; Sormani MP; Signori A; Calabrese M; Houssami N
Eur J Cancer; 2018 Nov; 104():39-46. PubMed ID: 30316869
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
